Integrated SIRI and Lipid Profile for Early Prediction of Bloodstream Infection in AML During Induction Chemotherapy
The SIRI-lipid integrated nomogram provides clinically applicable prediction of BSIs risk in AML induction therapy, with validated clinical utility. Elevated SIRI combined with atherogenic dyslipidemia, characterized by high LDL-C and low HDL-C, represents actionable risk indicators enabling early clinical interventions.
Authors
- Shen Zeng (ORCID: https://orcid.org/0000-0001-5450-8975)
- Huihan Zhao
- Guixiu Luo
Institutions
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/idr.s557948
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00